ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank80
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
2.03%
↑ 490% vs avg
Percentile
P80
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-0.52%
Historical baseline
PeriodValue
Q4 20252.03%
Q3 202521.17%
Q2 202525.06%
Q1 2025-21.62%
Q4 2024-6.07%
Q3 2024-5.23%
Q2 2024-5.79%
Q1 2024101.01%
Q4 2023-10.38%
Q3 2023-8.48%
Q2 20230.00%
Q1 2023-100.00%
Q4 20220.00%
Q3 20220.00%
Q2 20220.00%
Q1 20220.00%